Solutions Back to main Drug Development Cycle Back to Solutions Drug Development Cycle Discovery Back to Drug Development Cycle Our innovative preclinical solutions empower your drug development journey with cutting-edge analytics and insights from inception to preclinical stages. Learn more Quick Links Data Strategy Model-lnformed Drug Development Clinical Pharmacology, Drug Metabolism and Pharmacokinetics Phase I-III Clinical Trials Back to Drug Development Cycle We help you navigate complex trial phases efficiently with data-driven methods & strategies tailored to Phase I-III trials for accelerated drug development. Learn more Quick Links Adaptive Trial Designs Complex and Innovative Trial Design Model-lnformed Drug Development Clinical Development Strategy and Planning End-to-End Biometrics Axio® Data Monitoring Committee Data Strategy Regulatory Strategy Market Access Real-World Evidence Software for Trial Design Commercialization Back to Drug Development Cycle Maximize your market potential and optimize your commercial strategies with our advanced analytical methods, data science, and tailored commercialization solutions for data-driven commercial success. Learn more Quick Links Health Economics and Outcomes Research (HEOR) Market Access Regulatory Strategy Real-World Evidence Health and Technology Assessments stève consultants Real-World Evidence Solutions Back to Drug Development Cycle Harness the power of real-world data and real-world evidence to gather insights and shape future drug development cycles for enhanced efficacy and regulatory compliance. Find out more Quick Links Real-World Evidence Real-World Data Real-World Data Software Post-Authorization Safety Studies stève consultants Strategic Data Science and Analytical Methods Back to Solutions Strategic Data Science and Analytical Methods Clinical Trial Design Back to Strategic Data Science and Analytical Methods Craft optimal trial designs with our advanced analytical methods to enhance efficiency and increase the probability of success throughout your drug’s lifecycle. Learn more Quick Links Adaptive Trial Design Complex and Innovative Trial design Model-lnformed Drug Development Software for Trial Design Trial Delivery Back to Strategic Data Science and Analytical Methods Empower your trial delivery by transforming trial designs into actionable strategies with our data-driven approach to ensure seamless delivery and successful outcomes. Find out more Quick Links End-to-End Biometrics Data Management Early Phase Solutions Late Phase Solutions Axio® Data Monitoring Committee Safety & Regulatory Compliance FSP Outsourcing Outsourcing per Project Software for Trial Implementation Advanced Analytics Back to Strategic Data Science and Analytical Methods Unlock the power of data with our methods for actionable insights to drive informed decisions and optimize clinical trial outcomes. Learn more Quick Links Systematic Literature Reviews Complex and Innovative Trial Design Market Access Health Economics & Outcomes Research Real-World Evidence Real-World Data Health and Technology Assessments Specialty Areas Back to Strategic Data Science and Analytical Methods We offer tailored analytics solutions for your specialized or niche projects enabling you to optimize both efficiency and precision in drug development. Learn more Quick Links Synthetic Controls External Controls Rare Diseases Oncology Post-Authorization Safety Studies Decentralized Trials Pediatrics Delivery Models Back to Solutions Delivery Models Strategic Consulting Back to Delivery Models Enhance your clinical trial design with our strategic consulting services, featuring adaptive trial models and comprehensive regulatory guidance to ensure innovative, compliant, and successful trial outcomes. Learn more Quick Links Adaptive Trial Designs Advanced Analytics Regulatory Strategy Clinical Development Strategy & Planning Discovery and Pre-clinical Clinical Pharmacology, drug metabolism and pharmacokinetics Beyond Functional Service Provider Back to Delivery Models Experience the future of flexible strategic partnerships with Analytics on Demand, providing adaptive and innovative solutions that transcend traditional models to achieve unparalleled operational excellence. Learn more Quick Links Staff Augmentation Strategic Capacity Management Functional Service Provider Hybrid FSP Model Project-Based Analytical Solutions Back to Delivery Models Maximize efficiency and outcomes with our project-based services, delivering specialized expertise, end-to-end biometrics, and focused solutions for unique projects, ensuring timely completion and exceptional results. Project-Based Analytical Solutions Quick Links Data Management End-to-End Biometrics Data Submission support Axio® Data Monitoring Committee Medical Writing Software Solutions Back to Solutions Software Solutions Trial Design Software Back to Software Solutions Cytel's software platform enables precise trial design and simulation, utilizing adaptive and Bayesian tools to optimize protocols and accelerate drug development with confidence and efficiency. Learn more Quick Links East Horizon™ Platform for Trial Design Xact software suite, StatXact® Trial Implementation and Decision Support Software Back to Software Solutions Our unique software package streamlines trial implementation with intuitive solutions for protocol development, randomization, and patient management, optimizing operational efficiency and ensuring study success. Learn more Quick Links Enforesys LiveSLR® Software for Systematic Literature Reviews Back to Software Solutions Learn more Quick Links Therapeutic Areas Back to Solutions Therapeutic Areas Rare Diseases Oncology Central Nervous System Other Therapeutic Areas Our innovative preclinical solutions empower your drug development journey with cutting-edge analytics and insights from inception to preclinical stages. We help you navigate complex trial phases efficiently with data-driven methods & strategies tailored to Phase I-III trials for accelerated drug development. Maximize your market potential and optimize your commercial strategies with our advanced analytical methods, data science, and tailored commercialization solutions for data-driven commercial success. Harness the power of real-world data and real-world evidence to gather insights and shape future drug development cycles for enhanced efficacy and regulatory compliance. Craft optimal trial designs with our advanced analytical methods to enhance efficiency and increase the probability of success throughout your drug’s lifecycle. Empower your trial delivery by transforming trial designs into actionable strategies with our data-driven approach to ensure seamless delivery and successful outcomes. Unlock the power of data with our methods for actionable insights to drive informed decisions and optimize clinical trial outcomes. We offer tailored analytics solutions for your specialized or niche projects enabling you to optimize both efficiency and precision in drug development. Enhance your clinical trial design with our strategic consulting services, featuring adaptive trial models and comprehensive regulatory guidance to ensure innovative, compliant, and successful trial outcomes. Experience the future of flexible strategic partnerships with Analytics on Demand, providing adaptive and innovative solutions that transcend traditional models to achieve unparalleled operational excellence. Maximize efficiency and outcomes with our project-based services, delivering specialized expertise, end-to-end biometrics, and focused solutions for unique projects, ensuring timely completion and exceptional results. Cytel's software platform enables precise trial design and simulation, utilizing adaptive and Bayesian tools to optimize protocols and accelerate drug development with confidence and efficiency. Our unique software package streamlines trial implementation with intuitive solutions for protocol development, randomization, and patient management, optimizing operational efficiency and ensuring study success. About Us Back to main About Us Learn about our rich history, visionary leadership, and core values. Our mission and vision drive us to deliver excellence in drug development globally. Learn more Quick Links Our Experts Leadership Team Innovation Advisory Board Board of Directors Sustainability Learn about our rich history, visionary leadership, and core values. Our mission and vision drive us to deliver excellence in drug development globally. Insights Back to main Insights Explore Cytel’s Insights hub - your source for the latest news, event updates, and expert insights on advanced data analytics and data science. Explore now Quick Links Perspectives News and Events Resource Library Publications Explore Cytel’s Insights hub - your source for the latest news, event updates, and expert insights on advanced data analytics and data science. Careers Back to main Careers Join our innovative team at Cytel! Explore exciting career opportunities in data science and statistics, analytical methods, and regulatory strategy. Advance the future of human health with us. Learn more Quick Links Connect with Us Join our Talent Network Find our Latest Opportunities Join our innovative team at Cytel! Explore exciting career opportunities in data science and statistics, analytical methods, and regulatory strategy. Advance the future of human health with us. APAC Biopharma Industry Insights: Trends, Opportunities, and Challenges In the last 10 years, the Asia-Pacific (APAC) region has become a hotspot for clinical trials: the region contributed almost 50% of new clinical trial activity globally. The importance of APAC trials has also evolved, from the patients/sites being a contributor to address global patient enrollment issues to being a key player in global trials. This is driven by its large patient population, lower risk of competing trials, government support, pragmatic regulatory processes, lower cost of conducting trials, and strategic importance of Asian markets. Figure 1: Number of Clinical Trials by Country/Region Source: ClinicalTrials.gov database , sourced on April 14, 2023. There has been a noted shift in research priorities in APAC clinical trials from late-stage trials (Phase III or Phase IV) to early-stage (Phase I and Phase II). Reports from Trialtrove 2022 indicate that the Phase I clinical trials in 2022 accounted for a third of clinical trial activities. Today, the top five locations for Phase I clinical trials in Asia are China, Australia, South Korea, Japan, and India, with China alone responsible for nearly 40%. Figure 2: Shares of Phase I Trials in APAC (2012 – 2021) Source: In Vivo Pharma Intelligence, “ APAC As A Clinical Trial Powerhouse .” Overall, the data suggest an increasing level of innovation within APAC, particularly in China and Korea. A healthy proportion of Phase I trials suggests that novel chemical or biological entities are being developed in the region, rather than multinational Phase III trials that satisfy global regulatory requirements, or indeed Phase IV studies of mature drugs.

Figure 3: Top Therapy Areas for APAC Planned Clinical Trials in 2022 Source: GlobalData, Asia Pacific (APAC) Dominance in the Planned Clinical Trials for 2022 . Understanding planned clinical trials provides a cue on how the industry moves. As the biopharmaceutical industry advances, these APAC companies are facing the following challenges: Intense competition due to homogeneous products and new breakthrough points are required; The complexity of clinical trials continues to increase and if these trials are to be tested and verified using the traditional methods, the lifecycle will be relatively long with past success and practices no longer adequate predictors of future success; The need to identify commercially viable fields with the saturation of the oncology field. Identifying cures for presently incurable diseases, such as Alzheimer’s and epilepsy, rare diseases are indications that are evolving; and The growing demand for going global. Many of the biopharma companies in Asia, especially in China, are striving for significant impact on the global biopharma value chain. It is no longer an “in China for China only” scenario, with the innovative drugs only for the country. Companies such as Beigene and Legend are actively seeking commercial opportunities in global markets, particularly in the US, to offer lower-price alternatives to products from multinational companies. Companies will need to explore adoption of innovative methodologies in clinical trial design, data management, and study execution to address the complexity of trials, the mitigation of risks, and the handling of quantum of data. Further, there is an increased focus on operationalizing decentralized trials to streamline trial processes, on the better use of wearable devices and sensors to collect patient health data, and on the integration of machine learning and artificial intelligence to manage large amounts of data. There has also been an increasing trend of licensing of assets developed in China to global pharmaceutical companies, especially with cancer therapies. These APAC-based biopharma are partnering with global pharmaceutical companies to bring their early-stage assets to more advanced stages and clinical trials. In the space of innovative products, there has been an increasing focus on cell gene therapies in the region. With more CAR-T treatments expected to be approved in 2023 and more IND applications submitted to the FDA, it is important to look at accelerating new CGT trials (Figure 4) and the adequacy of clinical evidence to justify the cost of products. Figure 4: CGT Treatment-Related Clinical Trials by April 2021 Source: Deloitte, Outlook on Biopharma Innovation Trends in China , July 2021. This will be a great opportunity and it is with this intent that Cytel is expanding into the Asia-Pacific region. With our on-the-ground capabilities in Singapore, China, Australia, and Japan, we are now equipped to handle the biometric activity of global and regional trials, especially for sponsors who are looking at tapping into the benefits of each region. To help accelerate the innovation pace of the APAC biopharmaceutical industry and to seize development opportunities, we have taken the following strategies: Build a localized team, with presence in Shanghai, Beijing, and more cities in China, Japan, Australia, and Singapore. The local team will be able to act with urgency by working closely with the customers in the same time zone and by understanding the local culture. Further, this enables us to tap onto the talent pool in APAC, increasing the size and diversity of our talent resources in Cytel. Cultivate the quality biometrics offering in the industry and provide professional statistical software and research support that embraces the entire drug development process. We will continue to nurture the understandings of local markets, with a focus on small-to-mid-size biopharma and biotechnology companies and academic research institutions. We hope to accelerate their clinical trials, from pre-IND submission and protocol design to trial conduct, trial close-out, and commercialization. Promote our innovative offerings, beyond East and East Bayes focusing on providing targeted services in specific Asia countries — across consulting and trial design, data management and biostatistics, real-world evidence (RWE), real-world data (RWD), health economics and outcomes research (HEOR), and data monitoring committees (DMC). By planning the right trial with the optimal trial design and integrating strategy and efficient statistical tactics, it will shorten the drug development cycle, increase the success rate of research, and reduce R&D costs. Collaborate with local partners to build a more coherent and seamless service for clinical research. To date, we have established MOU with LIDE (pre-clinical CRO), HLT (digital solution CRO), and Trial Informatics (Imaging CRO) in the region. We look forward to establishing more partnerships to help streamline the clinical trial execution. APAC is a rapidly changing landscape with an abundance of opportunities as the region develops as an important drug development hub. Cytel aims to be a strategic partner with our customers and business partners in their journey from drug discovery to market approval. With our 35 years of rich experience in clinical trials, we have the capabilities to provide innovative solutions at all phases of drug development, assisting our customers to prove the value of their product. Interested in learning more? Contact us ! Related Articles Looking back, 2025 was a year of adjustment for biotech — instability shook an already fragile biopharma sector, AI gained significant momentum, the ability to merge open-source code with commercial software matured, and the use of real-world data (RWD) continued to increase. Most companies responded responsibly: pilots, internal capability builds, exploratory regulatory dialogue, and, unfortunately, […] Artificial intelligence has become an increasingly common tool in medical decision-making. Physicians consult large language models (LLMs) for diagnostic reasoning, documentation, and summarization; patients use them to interpret symptoms; and health systems continue to integrate them into clinical workflows. Yet a basic question remains insufficiently answered: How safe are these systems when their outputs influence […] Early-stage clinical development continues to challenge teams to make high-impact decisions with limited information. With so much uncertainty — scientific, operational, and financial — the way we design and use data in early trials has never been more critical. Today, forward-looking teams are rethinking trial design not only as a technical function, but as a […] At Cytel, we cultivate a culture of continuous learning, exploration, and creativity, fostering personal growth and steering the search for ground-breaking solutions. Our team of specialized, multidisciplinary thought leaders collaborate with colleagues and clients, channeling both individual expertise and collective intelligence. Through our blog channel, Cytel Perspectives, we share valuable insights supporting every stage of your research—from the preclinical phase and trial design to market access and reimbursement. Subscribe to our newsletter today to stay informed and inspired. Claim your free 30-minute strategy session Book a free, no-obligation strategy session with a Cytel expert to get advice on how to improve your drug’s probability of success and plot a clearer route to market.